BAKER BROS. ADVISORS LP – Aligos Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$2.28M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-9.09%
quarter
Aligos Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -228K | $1.1 | 2.07M | |
| Q2 2022 | share | 0.00% | 0 shares | -1.95M | $1.21 | 2.07M | |
| Q1 2022 | share | 0.00% | 0 shares | -20.18M | $2.15 | 2.07M | |
| Q4 2021 | share | 0.00% | 0 shares | -7.55M | $11.97 | 2.07M | |
| Q3 2021 | share | Increase | +28.97% | 466.4K shares | -615K | $15.51 | 2.07M |
| Q2 2021 | share | 0.00% | 0 shares | -3.79M | $20.39 | 1.61M | |
| Q1 2021 | share | 0.00% | 0 shares | -7.90M | $22.74 | 1.61M | |
| Q4 2020 | share | Increase | 0.00% | 1.61M shares | 44.51M | $27.65 | 1.61M |